Fortress Biotech to Participate in December 2019 Investor Conferences

    NEXT STORY
    FGK Clinical Research Signs Five-Year Agreement with OmniComm Systems for Multiple eClinical Products
    PREV STORY
    Intercept Pharmaceuticals Appoints Jason Campagna as Chief Medical Officer
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    SCYNEXIS Reports Third Quarter 2020 Financial Results and Provides Company Update

    author_avatar
    NASDAQ Market News

    Fluidigm Introduces High-Parameter Maxpar Immune Monitoring Panel for Translational and Clinical Research

    author_avatar
    NASDAQ Market News

    Teleflex Announces First Patient Enrollment in CTO-PCI IDE Study

    author_avatar
    NASDAQ Market News